William Slone, Ph.D.
About William Slone, Ph.D.
William Slone, Ph.D., serves as the Director of Development at Locus Biosciences, Inc., where he has worked since 2021. He possesses expertise in program design for translational medicine and has a strong background in clinical research and cancer biology.
Work at Locus Biosciences
William Slone, Ph.D. serves as the Director of Development at Locus Biosciences, Inc. since 2021. In this role, he focuses on advancing the company's development initiatives, particularly in the areas of translational medicine. His responsibilities include overseeing clinical protocol development for novel chemical entities and biological products, ensuring that projects align with regulatory standards and scientific rigor.
Education and Expertise
William Slone earned his Doctor of Philosophy (Ph.D.) in Cancer Cell Biology from West Virginia University, completing his studies from 2011 to 2016. He also holds a Bachelor's degree in Clinical Laboratory Science/Medical Technology from the same institution, which he obtained from 2007 to 2011. His expertise encompasses program design for translational medicine, specifically targeting cardiovascular, neurological, oncology, and orphan indications.
Background
Before joining Locus Biosciences, William Slone held various positions that contributed to his expertise in clinical research and methodology. He worked as a Fellow in Clinical Research Methodology at Worldwide Clinical Trials from 2016 to 2019 and later served as Assistant Director in the same organization from 2019 to 2021. His early career included roles as an Undergraduate Research Assistant and Postdoctoral Fellow at West Virginia University Research Corporation.
Achievements
William Slone has been involved in initiatives aimed at evaluating healthcare resource utilization to enhance patient access to new therapeutic agents. His skills in scientific writing and presentation are particularly noted in the context of cancer research and molecular biology, contributing to his effectiveness in clinical protocol development.